Health Condition 1: N711- Chronic inflammatory disease of uterus
Conditions
Interventions
Intervention1: Powder of Amla: Patient will be given oral
medicine powder of Amla (
Emblica officinalis gaertn) in
capsule form 6 gm with normal
water in three divided doses
from D-6 to D-25 of cycle
Sponsors
Government Nizamia tibbi college
Eligibility
Inclusion criteria
Inclusion criteria: Female patients age between 20 to 45 years Unmarried married and non pregnant Diagnosed cases of uterine fibroids and not resolved cases after treatment Uterine fibroids one to multiple (1 to 5) less than 5 centimeter USG report Symptomatic fibroids (intramural) Controlled diabetes mellitus (RBS less than 200 HbA1c 6.4 percent FBS 70 to 99 milligram per decilitre and PLBS less than 140 milligram per decilitre Controlled hypertension less than 130 over 80 mmHg Patients who is ready to participate in the study and who are willing to sign consent form
Exclusion criteria
Exclusion criteria: Women who attained menopause Pregnant and lactating women Uterine fibroid greater than 5 centimeter Severe anemia (Hb less than 8.0 gram per decilitre) Women with high risk cases like severe cardiac diseases hepato renal diseases and respiratory diseases Combined with malignant tumors including reproductive and other systems Patients with co morbidities (un controlled hypertension and uncontrolled diabetes mellitus)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess improvements in fibroid associated symptoms (VAS PBAC UFS QoL( specifically 6 12 point scale) ( pre and post treatment)Timepoint: 0th day and 90th day | — |
Secondary
| Measure | Time frame |
|---|---|
| To reduce the uterine fibroid size (USG report) (pre and post treatment) To evaluate safety and tolerability of the treatment Timepoint: Baseline 0 Day 90 | — |
Countries
India
Contacts
Public ContactDr Nishath parveen
Government Nizamia tibbi college and general hospital
Outcome results
None listed